# Dinesh Khanna

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/dinesh-khanna/

## Facts

| Field | Value |
| --- | --- |
| Citations | 58,574 |
| Field | Systemic Sclerosis and Related Diseases |
| h-index | 103 |
| i10-index | 465 |
| Last Known Institution | University of Michigan |
| OpenAlex ID | https://openalex.org/A5073269240 |
| ORCID iD | https://orcid.org/0000-0003-1412-4453 |
| Works | 813 |

## Researcher papers

- [2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology/)
- [2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis](https://scholariq.org/papers/2012-update-of-the-2008-american-college-of-rheumatology-recommendations-for-the/)
- [2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology-2/)
- [2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia](https://scholariq.org/papers/2012-american-college-of-rheumatology-guidelines-for-management-of-gout-part-1/)
- [American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials](https://scholariq.org/papers/american-college-of-rheumatology-european-league-against-rheumatism-provisional/)
- [2020 American College of Rheumatology Guideline for the Management of Gout](https://scholariq.org/papers/2020-american-college-of-rheumatology-guideline-for-the-management-of-gout-2/)
- [2020 American College of Rheumatology Guideline for the Management of Gout](https://scholariq.org/papers/2020-american-college-of-rheumatology-guideline-for-the-management-of-gout/)
- [Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma](https://scholariq.org/papers/myeloablative-autologous-stem-cell-transplantation-for-severe-scleroderma/)
- [Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease](https://scholariq.org/papers/effects-of-1-year-treatment-with-cyclophosphamide-on-outcomes-at-2-years-in/)

## Researcher topics

- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Inflammatory Myopathies and Dermatomyositis](https://scholariq.org/topics/inflammatory-myopathies-and-dermatomyositis/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Researcher university

- [University of Michigan](https://scholariq.org/institutions/university-of-michigan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.